Navitoclax, Venetoclax and Decitabine
A Phase 1 Study of Triplet Therapy With Navitoclax, Venetoclax, and Decitabine for High-risk Myeloid Malignancies
What's the purpose of the trial?
The purpose of this research study is to test the safety of a new three drug combination of navitoclax, decitabine, and venetoclax to treat advanced myeloid malignancies.
The names of the drugs involved in this study are:
* Venetoclax
* Decitabine
* Navitoclax
Trial status
Active, Not Recruiting
Phase
Phase 1
Enrollment
16
Last Updated
2 months ago
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.